Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Sofosbuvir with velpatasvir and voxilaprevir,"Hepatitis C, second-line after prior direct-acting antiviral treatment",Sofosbuvir with velpatasvir and voxilaprevir,Only if cost neutral or cost saving,,
